Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-26

FDA Approved: SEVELAMER CARBONATE — Original Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic version of sevelamer carbonate (Sevelamer carbonate) from Exelan Pharmaceuticals Inc. for the treatment of hyperphosphatemia in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

ORIG AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)